Funding program supports R15-eligible PIs in conducting basic pain research, fostering interdisciplinary collaborations, and engaging students.
NIH supports small-scale mechanistic or minimal-risk clinical trials at health professional and graduate schools with limited NIH funding, enhancing student research experiences and institutional research capacity.
Funding for research developing non-addictive pain treatments through early drug discovery to support the Pain Therapeutics Development Program.
Supports research in health professional and graduate schools lacking major NIH funding, enhancing research environments and student involvement, with applicants requiring <$6 million NIH funding in 4 of last 7 years.
NIH supports milestone-driven development of non-addictive small molecule and biologic pain treatments, from lead optimization through Phase I testing, to prepare candidates for Phase II trials.
NIH supports research education experiences that strengthen the biomedical, behavioral and clinical research workforce, recruit researchers and improve understanding of research; clinical trials are not allowed.